Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;31(19):2809-2820.
doi: 10.2174/0109298673250291231121052433.

Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients

Flávia Maria Borges Vigil  1   2 , Pedro Alves Soares Vaz de Castro  1 , Ursula Gramiscelli Hasparyk  1 , Victória Soares Bartolomei  1 , Ana Cristina Simões E Silva  1
Affiliations

Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients

Flávia Maria Borges Vigil et al. Curr Med Chem. 2024.

Abstract

Background: The impact of treatments, suppressing the immune system, persistent hyperparathyroidism, and other risk factors on mineral and bone disorder (MBD) after kidney transplantation is well-known. However, there is limited knowledge about their effect on bone metabolism biomarkers. This study aimed to investigate the influence of kidney transplant on these markers, comparing them to patients undergoing hemodialysis and healthy individuals.

Methods: In this cross-sectional study, three groups were included: kidney transplant patients (n = 57), hemodialysis patients (n = 26), and healthy controls (n = 31). Plasma concentrations of various bone metabolism biomarkers, including Dickkopf-related protein 1, osteoprotegerin, osteocalcin, osteopontin, sclerostin, and fibroblast growth factor 23, were measured. Associations between these biomarkers and clinical and laboratory data were evaluated.

Results: A total of 114 patients participated. Transplant recipients had significantly lower levels of Dickkopf-related protein 1, osteoprotegerin, osteocalcin, osteopontin, sclerostin, and fibroblast growth factor 23 compared to hemodialysis patients. Alkaline phosphatase levels positively correlated with osteopontin (r = 0.572, p < 0.001), while fibroblast growth factor 23 negatively correlated with 25-hydroxyvitamin D (r = -0.531, p = 0.019). The panel of bone biomarkers successfully predicted hypercalcemia (area under the curve [AUC] = 0.852, 95% confidence interval [CI] = 0.679-1.000) and dyslipidemia (AUC = 0.811, 95% CI 0.640-0.982) in transplant recipients.

Conclusion: Kidney transplantation significantly improves mineral and bone disorders associated with end-stage kidney disease by modulating MBD markers and reducing bone metabolism markers, such as Dickkopf-related protein 1, osteoprotegerin, osteocalcin, osteopontin, and sclerostin. Moreover, the panel of bone biomarkers effectively predicted hypercalcemia and dyslipidemia in transplant recipients.

Keywords: Kidney transplantation; biomarkers.; bone metabolism; chronic kidney disease; hemodialysis; renal osteodystrophy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Kidney disease: Improving global outcomes (KDIGO) CKD-MBD update work group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2011,2017(7),1-59
    1. Bouquegneau A.; Salam S.; Delanaye P.; Eastell R.; Khwaja A.; Bone disease after kidney transplantation. Clin J Am Soc Nephrol 2016,11(7),1282-1296 - DOI - PubMed
    1. Moe S.M.; Chen N.X.; Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008,19(2),213-216 - DOI - PubMed
    1. Mazzaferro S.; Pasquali M.; Taggi F.; Baldinelli M.; Conte C.; Muci M.L.; Pirozzi N.; Carbone I.; Francone M.; Pugliese F.; Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol 2009,4(3),685-690 - DOI - PubMed
    1. Mazzaferro S.; Pasquali M.; Pugliese F.; Barresi G.; Carbone I.; Francone M.; Sardella D.; Taggi F.; Serum levels of calcification inhibition proteins and coronary artery calcium score: Comparison between transplantation and dialysis. Am J Nephrol 2007,27(1),75-83 - DOI - PubMed